glp-1 receptor agonist pancreatitis risk meta-analysis Glucagon-Like Peptide-1 Agonists Use... : American Journal of Gastroenterology GLP-1 Receptor Agonists as Treatments

doi: 10.1016/j.brainres.2018.11.007

ClinicalTrials.gov (2022)

The FDA has approved certain medications (Victoza, Ozempic, Trulicity) for cardiovascular risk reduction in patients with established cardiovascular disease and type 2 diabetes, and Wegovy for cardiovascular risk reduction in adults with established cardiovascular disease who have overweight or obesity

Dillon JS, Tanizawa Y, Wheeler MB, Leng XH, Ligon BB, Rabin DU, Yoo-Warren H, Permutt MA, and Boyd AE, 3rd

I = 0.0%, p = 0.656) (Supplementary Figure D5)

Bisphosphonates (such as alendronic acid) remain first-line treatment for osteoporosis and can be safely co-prescribed with GLP-1 receptor agonists